These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34871095)

  • 21. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of [11C]rifampin pharmacokinetics within Mycobacterium tuberculosis-infected mice by using dynamic positron emission tomography bioimaging.
    DeMarco VP; Ordonez AA; Klunk M; Prideaux B; Wang H; Zhuo Z; Tonge PJ; Dannals RF; Holt DP; Lee CK; Weinstein EA; Dartois V; Dooley KE; Jain SK
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5768-74. PubMed ID: 26169396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment.
    Pienaar E; Cilfone NA; Lin PL; Dartois V; Mattila JT; Butler JR; Flynn JL; Kirschner DE; Linderman JJ
    J Theor Biol; 2015 Feb; 367():166-179. PubMed ID: 25497475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spatial multiomic profiling reveals the novel polarization of foamy macrophages within necrotic granulomatous lesions developed in lungs of C3HeB/FeJ mice infected with
    Seto S; Nakamura H; Guo TC; Hikichi H; Wakabayashi K; Miyabayashi A; Nagata T; Hijikata M; Keicho N
    Front Cell Infect Microbiol; 2022; 12():968543. PubMed ID: 36237431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clofazimine protects against Mycobacterium tuberculosis dissemination in the central nervous system following aerosol challenge in a murine model.
    Baijnath S; Moodley C; Ngcobo B; Singh SD; Kruger HG; Arvidsson PI; Naicker T; Pym A; Govender T
    Int J Antimicrob Agents; 2018 Jan; 51(1):77-81. PubMed ID: 28843822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of 5-chloro-pyrazinamide in mice infected with Mycobacterium tuberculosis or Mycobacterium bovis.
    Ahmad Z; Tyagi S; Minkowsk A; Almeida D; Nuermberger EL; Peck KM; Welch JT; Baughn AS; Jacobs WR; Grosset JH
    Indian J Med Res; 2012 Nov; 136(5):808-14. PubMed ID: 23287128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On-Slide Heat Sterilization Enables Mass Spectrometry Imaging of Tissue Infected with High-Threat Pathogens Outside of Biocontainment: A Study Directed at
    Wang N; Sarathy JP; Zimmerman M; Kaya F; Wang H; Dartois V; Carter CL
    J Am Soc Mass Spectrom; 2021 Nov; 32(11):2664-2674. PubMed ID: 34672552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-12p40 overexpression promotes interleukin-12p70 and interleukin-23 formation but does not affect bacille Calmette-Guérin and Mycobacterium tuberculosis clearance.
    Olleros ML; Vesin D; Martinez-Soria E; Allenbach C; Tacchini-Cottier F; Pache JC; Marchal G; Rahman J; Fernández C; Izui S; Garcia I
    Immunology; 2007 Nov; 122(3):350-61. PubMed ID: 17623032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An adjunctive therapeutic vaccine against reactivation and post-treatment relapse tuberculosis.
    Miyata T; Cheigh CI; Casali N; Goodridge A; Marjanovic O; Kendall LV; Riley LW
    Vaccine; 2012 Jan; 30(2):459-65. PubMed ID: 22079078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Photoinactivation of Mycobacteria in vitro and in a new murine model of localized Mycobacterium bovis BCG-induced granulomatous infection.
    O'Riordan K; Sharlin DS; Gross J; Chang S; Errabelli D; Akilov OE; Kosaka S; Nau GJ; Hasan T
    Antimicrob Agents Chemother; 2006 May; 50(5):1828-34. PubMed ID: 16641456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcitriol enhances pyrazinamide treatment of murine tuberculosis.
    Zhang J; Guo M; Huang ZX; Bao R; Yu Q; Dai M; Wang X; Rao Y
    Chin Med J (Engl); 2019 Sep; 132(17):2089-2095. PubMed ID: 31425356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of Bactericidal Drug Activity and Treatment Outcome in a Mouse Tuberculosis Model Using a Clinical Beijing Strain.
    Mourik BC; de Knegt GJ; Verbon A; Mouton JW; Bax HI; de Steenwinkel JEM
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739784
    [No Abstract]   [Full Text] [Related]  

  • 33. Sterilizing Effects of Novel Regimens Containing TB47, Clofazimine, and Linezolid in a Murine Model of Tuberculosis.
    Yu W; Yusuf B; Wang S; Tian X; Hameed HMA; Lu Z; Chiwala G; Alam MS; Cook GM; Maslov DA; Zhong N; Zhang T
    Antimicrob Agents Chemother; 2021 Sep; 65(10):e0070621. PubMed ID: 34280022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic evaluation of the penetration of antituberculosis agents in rabbit pulmonary lesions.
    Kjellsson MC; Via LE; Goh A; Weiner D; Low KM; Kern S; Pillai G; Barry CE; Dartois V
    Antimicrob Agents Chemother; 2012 Jan; 56(1):446-57. PubMed ID: 21986820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosis.
    Rosenthal IM; Tasneen R; Peloquin CA; Zhang M; Almeida D; Mdluli KE; Karakousis PC; Grosset JH; Nuermberger EL
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4331-40. PubMed ID: 22664964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Respirable Clofazimine Particles Produced by Air Jet Milling Technique Are Efficacious in Treatment of BALB/c Mice with Chronic Mycobacterium tuberculosis Infection.
    Brunaugh AD; Walz A; Warnken Z; Pearce C; Munoz Gutierrez J; Koleng JJ; Smyth HDC; Gonzalez-Juarrero M
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0018622. PubMed ID: 35943265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SILA-421 activity in vitro against rifampicin-susceptible and rifampicin-resistant Mycobacterium tuberculosis, and in vivo in a murine tuberculosis model.
    de Knegt GJ; Bakker-Woudenberg IA; van Soolingen D; Aarnoutse R; Boeree MJ; de Steenwinkel JE
    Int J Antimicrob Agents; 2015 Jul; 46(1):66-72. PubMed ID: 25951996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prospects for development of new antituberculous drugs].
    Tomioka H
    Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis.
    Tyagi S; Ammerman NC; Li SY; Adamson J; Converse PJ; Swanson RV; Almeida DV; Grosset JH
    Proc Natl Acad Sci U S A; 2015 Jan; 112(3):869-74. PubMed ID: 25561537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.